Health In Tech Inc

Health In Tech Inc (HIT) Stock Analysis

$0.524

-0.048 (-9.14%)At close

Loading chart…
High
0.595
Open
0.548
VWAP
0.55
Volume
10.10K
Mkt Cap
—
Low
0.520
Amount
5.52K
EV/EBITDA, TTM
-1.44

Health In Tech, Inc. is an AI-enabled insurance technology platform company. The Company offers a marketplace that improves processes in the healthcare industry through vertical integration, process simplification, and automation. It offers a marketplace designed to create healthcare plan solutions while streamlining processes through vertical integration, process simplification, and automation. Its services are delivered through three subsidiaries: Stone Mountain Risk, LLC (SMR), International Captive Exchange, LLC (ICE), and HI Card LLC’s HI Card platform (HI Card). The SMR is a program manager specializing in customized self-funded programs for small businesses. ICE is a managing general underwriter. ICE assists with underwriting activities through its Web-based SaaS quoting platform, Enhance Do It Yourself Benefit System (eDIYBS). HI Card seeks to simplify healthcare management with a single standardized transaction and service platform.

AI analysis of Health In Tech Inc (HIT)

Buy

Health In Tech, Inc. appears to be a good buy right now due to its current price of $0.58, which is significantly below its 52-week high of $3.11, indicating potential for recovery. The RSI is at 43.33, suggesting the stock is not overbought, and the recent 5-day change of +9.12% shows positive momentum. However, the main risk is the projected EPS of -0.06 for the next earnings report, indicating ongoing profitability challenges.

Valuation Metrics

The current forward P/E ratio for Health In Tech Inc (HIT) is 8.80, compared to its 5-year average forward P/E of 61.83.

Forward P/E

Fair
5Y Average P/E
61.83
Current P/E
8.80
Overvalued
117.80
Undervalued
5.86

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
5.95
Current EV/EBITDA
-1.44
Overvalued
18.02
Undervalued
-6.12

Forward P/S

Fair
5Y Average P/S
1.58
Current P/S
0.70
Overvalued
2.86
Undervalued
0.30

Events Timeline

2026-10-20 (ET)

07:00:00

Health In Tech Appoints Sanjay Shrestha as CEO

2026-09-30 (ET)

16:30:00

Health In Tech Updates 2026 Revenue Outlook to $33 Million

16:30:00

Health In Tech Launches HitRix Platform, Shares Up 23%

2026-09-04 (ET)

11:30:00

Selling Stockholders Plan to Sell 29.53M Shares of Class A Common Stock

2026-08-13 (ET)

17:00:00

Health In Tech Sees 2026 Revenue of $45M-$50M

News

HIT FAQ — answered by Alphio AI

Health In Tech, Inc. is an AI-enabled insurance technology platform company. The Company offers a marketplace that improves processes in the healthcare industry through vertical integration, process simplification, and automation. It offers a marketplace designed to create healthcare plan solutions while streamlining processes through vertical integration, process simplification, and automation. Its services are delivered through three subsidiaries: Stone Mountain Risk, LLC (SMR), International Captive Exchange, LLC (ICE), and HI Card LLC’s HI Card platform (HI Card). The SMR is a program manager specializing in customized self-funded programs for small businesses. ICE is a managing general underwriter. ICE assists with underwriting activities through its Web-based SaaS quoting platform, Enhance Do It Yourself Benefit System (eDIYBS). HI Card seeks to simplify healthcare management with a single standardized transaction and service platform. It operates in the Financials sector.

Health In Tech, Inc. appears to be a good buy right now due to its current price of $0.58, which is significantly below its 52-week high of $3.11, indicating potential for recovery. The RSI is at 43.33, suggesting the stock is not overbought, and the recent 5-day change of +9.12% shows positive momentum. However, the main risk is the projected EPS of -0.06 for the next earnings report, indicating ongoing profitability challenges.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

Related articles

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading